Raymond Pranata1, Ian Huang2, Michael Anthonius Lim3, Eka Julianta Wahjoepramono4, Julius July4. 1. Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia. Electronic address: raymond_pranata@hotmail.com. 2. Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; Department of Internal Medicine, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia. 3. Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia. 4. Department of Neurosurgery, Medical Faculty of Pelita Harapan University, Lippo Village Tangerang, Neuroscience Centre Siloam Hospital, Lippo Village Tangerang, Indonesia.
Abstract
BACKGROUND: We conducted a systematic review and meta-analysis to evaluate the latest evidence on the association between cerebrovascular, and cardiovascular diseases and poor outcome in patients with Coronavirus Disease 2019 (COVID-19) pneumonia. METHODS: A comprehensive systematic literature search was performed using PubMed, SCOPUS, EuropePMC, and Cochrane Central Database. The outcome of interest was composite poor outcome that comprised of mortality and severe COVID-19. RESULTS: A total of 4448 patients were obtained from 16 studies. Cerebrovascular disease was associated with an increased composite poor outcome (RR 2.04 [1.43,2.91], p<0.001; I2: 77%). Subgroup analysis revealed that cerebrovascular disease was associated with mortality (RR 2.38 [1.92,2.96], p<0.001; I2: 0%) and showed borderline significance for severe COVID-19 (RR 1.88 [1.00,3.51], p = 0.05; I2: 87%). Cardiovascular disease was associated with increased composite poor outcome (RR 2.23 [1.71,2.91], p<0.001; I2: 60%), mortality (RR 2.25 [1.53,3.29], p<0.001; I2: 33%) and severe COVID-19 (RR 2.25 [1.51,3.36], p<0.001; I2: 76%). Meta-regression demonstrate that the association was not influenced by gender, age, hypertension, diabetes, and respiratory comorbidities. Furthermore, the association between cerebrovascular disease and poor outcome was not affected by cardiovascular diseases and vice versa. CONCLUSION: Cerebrovascular and cardiovascular diseases were associated with an increased risk for poor outcome in patients with COVID-19.
BACKGROUND: We conducted a systematic review and meta-analysis to evaluate the latest evidence on the association between cerebrovascular, and cardiovascular diseases and poor outcome in patients with Coronavirus Disease 2019 (COVID-19) pneumonia. METHODS: A comprehensive systematic literature search was performed using PubMed, SCOPUS, EuropePMC, and Cochrane Central Database. The outcome of interest was composite poor outcome that comprised of mortality and severe COVID-19. RESULTS: A total of 4448 patients were obtained from 16 studies. Cerebrovascular disease was associated with an increased composite poor outcome (RR 2.04 [1.43,2.91], p<0.001; I2: 77%). Subgroup analysis revealed that cerebrovascular disease was associated with mortality (RR 2.38 [1.92,2.96], p<0.001; I2: 0%) and showed borderline significance for severe COVID-19 (RR 1.88 [1.00,3.51], p = 0.05; I2: 87%). Cardiovascular disease was associated with increased composite poor outcome (RR 2.23 [1.71,2.91], p<0.001; I2: 60%), mortality (RR 2.25 [1.53,3.29], p<0.001; I2: 33%) and severe COVID-19 (RR 2.25 [1.51,3.36], p<0.001; I2: 76%). Meta-regression demonstrate that the association was not influenced by gender, age, hypertension, diabetes, and respiratory comorbidities. Furthermore, the association between cerebrovascular disease and poor outcome was not affected by cardiovascular diseases and vice versa. CONCLUSION:Cerebrovascular and cardiovascular diseases were associated with an increased risk for poor outcome in patients with COVID-19.
Authors: Sebastian Bertram; Thiemo Pfab; Christian Albert; Sven Schmidt; Jürgen Passfall; Martin Haesner; Maximilian Seidel; Bodo Hölzer; Felix S Seibert; Adrian Doevelaar; Benjamin Rohn; Panagiota Zgoura; Nina Babel; Timm H Westhoff Journal: Ther Apher Dial Date: 2022-03-29 Impact factor: 2.195
Authors: Mayank Batra; Runxia Tian; Chongxu Zhang; Emile Clarence; Camila Sofia Sacher; Justin Nestor Miranda; Justin Rafa O De La Fuente; Megan Mathew; Desmond Green; Sayari Patel; Maria Virginia Perez Bastidas; Sara Haddadi; Mukunthan Murthi; Miguel Santiago Gonzalez; Shweta Kambali; Kayo H M Santos; Huda Asif; Farzaneh Modarresi; Mohammad Faghihi; Mehdi Mirsaeidi Journal: Sci Rep Date: 2021-02-10 Impact factor: 4.379
Authors: Wenjie Tian; Wanlin Jiang; Jie Yao; Christopher J Nicholson; Rebecca H Li; Haakon H Sigurslid; Luke Wooster; Jerome I Rotter; Xiuqing Guo; Rajeev Malhotra Journal: J Med Virol Date: 2020-07-11 Impact factor: 20.693
Authors: E Moro; A Priori; E Beghi; R Helbok; L Campiglio; C L Bassetti; E Bianchi; L F Maia; S Ozturk; F Cavallieri; M Zedde; J Sellner; D Bereczki; M Rakusa; G Di Liberto; A Sauerbier; A Pisani; A Macerollo; R Soffietti; P Taba; M Crean; A Twardzik; C Oreja-Guevara; B Bodini; T M Jenkins; T J von Oertzen Journal: Eur J Neurol Date: 2020-07-23 Impact factor: 6.288
Authors: Eman A Toraih; Rami M Elshazli; Mohammad H Hussein; Abdelaziz Elgaml; Mohamed Amin; Mohammed El-Mowafy; Mohamed El-Mesery; Assem Ellythy; Juan Duchesne; Mary T Killackey; Keith C Ferdinand; Emad Kandil; Manal S Fawzy Journal: J Med Virol Date: 2020-07-06 Impact factor: 20.693